Citius Pharmaceuticals, Inc.
CTXR · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $17,501 | $17,270 | $46,362 | $145,113 |
| - Cash | $6,089 | $26 | $1,100 | $3,252 |
| + Debt | $882 | $932 | $205 | $263 |
| Enterprise Value | $12,293 | $18,175 | $45,466 | $142,124 |
| Revenue | $0 | $0 | $0 | $156 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$41 | -$56 | -$55 | -$54 |
| % Margin | – | – | – | -34.4% |
| EBITDA | -$8,726 | -$11,191 | -$9,985 | -$10,997 |
| % Margin | – | – | – | -7,052.6% |
| Net Income | -$8,790 | -$10,917 | -$9,768 | -$10,790 |
| % Margin | – | – | – | -6,920.1% |
| EPS Diluted | -0.8 | -1.27 | -1.3 | -1.7 |
| % Growth | 37% | 2.3% | 23.5% | – |
| Operating Cash Flow | -$5,407 | -$4,539 | -$4,726 | -$5,913 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$5,407 | -$4,539 | -$4,726 | -$5,913 |